Table 8 End of treatment distribution of the study group
From: PET/CT vs CECT in assessment of therapeutic response in lymphoma
Number | Percent | |
|---|---|---|
CT | ||
Complete regression | 5 | 25.0 |
Progression disease | 6 | 30.0 |
Partial regression | 4 | 20.0 |
Stationary disease | 5 | 25.0 |
PET | ||
Complete regression | 9 | 45.0 |
Progression disease | 7 | 35.0 |
Partial regression | 3 | 15.0 |
Stationary disease | 1 | 5.0 |